ESPR
Esperion Therapeutics Inc
Price:  
1.17 
USD
Volume:  
2,321,688
United States | Biotechnology

ESPR Fair Value

-430.4 %
Upside

What is the fair value of ESPR?

As of 2025-07-07, the Fair Value of Esperion Therapeutics Inc (ESPR) is -3.87 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.17 USD, the upside of Esperion Therapeutics Inc is -430.4%.

Is ESPR a good investment?

With the market price of 1.17 USD and our fair value calculation, Esperion Therapeutics Inc (ESPR) is not a good investment. Investing in ESPR stocks now will result in a potential loss of 430.4%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.17 USD
Stock Price
-3.87 USD
Fair Price
FAIR VALUE CALCULATION

ESPR Fair Value

Peter Lynch's formula is:

ESPR Fair Value
= Earnings Growth Rate x TTM EPS
ESPR Fair Value
= 5 x -0.77
ESPR Fair Value
= -3.87

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
12-202012-202112-202212-202312-20245Y Avg
Net income-143.6-269.1-233.7-209.25-51.74-181
YoY growth-47.7%-87.4%13.2%10.5%75.3%-7.2%

ESPR Fair Value - Peers Benchmarking

Market Cap (mil)EPS Fair Value Upside
a
Abbvie Inc334,3442.419.1-89.9%
Amgen Inc160,3671155.17-81.5%
Gilead Sciences Inc139,0094.8119.887.3%
Regeneron Pharmaceuticals Inc59,09841.71,041.890.3%
Catalyst Pharmaceuticals Inc2,6181.640.4588.5%
MannKind Corp1,0940.12.44-32.3%
Akebia Therapeutics Inc951-0.2-2.31-163.8%
MiMedx Group Inc9360.33.21-49.4%
Anika Therapeutics Inc161-4-19.79-275.9%
Theratechnologies Inc147-0.1-0.72-117.1%

ESPR Fair Value - Key Data

Market Cap (mil)232
P/E-
Forward P/E-
EPS-0.77
Avg earnings growth rate-7.2%
TTM earnings-153

ESPR Fair Value - Formula's Origin

Peter Lynch is one of the most legendary investors/fund managers of all time. His philosophy for stock investing is very simple and straightforward: he invests in stocks that are undervalued, meaning its P/E is less than or equal to its earnings growth rate. He believes that if a stock is trading at its fair value, the PEG ratio, which was also invented by him, should be 1.

Therefore, his formula to determine a company's fair value is:

Peter Lynch Fair Value = Earnings Growth Rate * EPS * PEG

PEG is set to 1 so we can ignore it in the calculation. Based on the formula, if the earnings growth rate of a company is 15%, Peter Lynch is willing to buy its share up to P/E = 15.